Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John’s wort extract (STW 3-VI) and fluoxetine

Superoxide dismutases: a physiopharmacological update

(2010) A. Valdivia et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

(2009) Andrew H. Miller et al.   BIOLOGICAL PSYCHIATRY

Mechanism of St. John's wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system

(2009) O. Grundmann et al.   NEUROPHARMACOLOGY

Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

(2009) Andreas Keller et al.   PLoS One

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

(2008) Filip Simunovic et al.   BRAIN

Therapeutic Potential of Fluoxetine in Neurological Disorders

(2008) Jop P. Mostert et al.   CNS Neuroscience & Therapeutics

Microarray comparative genomic hybridization analysis of 59 patients with schizophrenia

(2008) Takeshi Mizuguchi et al.   JOURNAL OF HUMAN GENETICS

Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders

(2008) H ANISMAN et al.   PROGRESS IN NEUROBIOLOGY

Impact of fluoxetine on the human brain in multiple sclerosis as quantified by proton magnetic resonance spectroscopy and diffusion tensor imaging

(2008) Paul E. Sijens et al.   PSYCHIATRY RESEARCH-NEUROIMAGING